171 related articles for article (PubMed ID: 30239062)
1. Hepcidin-25/erythroferrone ratio predicts improvement of anaemia in haemodialysis patients treated with ferric citrate hydrate.
Hara M; Nakamura Y; Suzuki H; Asao R; Nakamura M; Nishida K; Kenmotsu S; Inagaki M; Tsuji M; Kiuchi Y; Ohsawa I; Goto Y; Gotoh H
Nephrology (Carlton); 2019 Aug; 24(8):819-826. PubMed ID: 30239062
[TBL] [Abstract][Full Text] [Related]
2. Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis.
Honda H; Kobayashi Y; Onuma S; Shibagaki K; Yuza T; Hirao K; Yamamoto T; Tomosugi N; Shibata T
PLoS One; 2016; 11(3):e0151601. PubMed ID: 26978524
[TBL] [Abstract][Full Text] [Related]
3. Saccharated ferric oxide attenuates haematopoietic response induced by epoetin beta pegol in patients undergoing haemodialysis.
Iwasaki T; Fujimori A; Nakanishi T; Okada S; Hanawa N; Hasuike Y; Kuragano T
BMC Nephrol; 2021 Apr; 22(1):124. PubMed ID: 33832448
[TBL] [Abstract][Full Text] [Related]
4. Marathon Run-induced Changes in the Erythropoietin-Erythroferrone-Hepcidin Axis are Iron Dependent.
Tomczyk M; Kortas J; Flis D; Kaczorowska-Hac B; Grzybkowska A; Borkowska A; Lewicka E; Dabrowska-Kugacka A; Antosiewicz J
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32316587
[TBL] [Abstract][Full Text] [Related]
5. Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.
Pirotte M; Fillet M; Seidel L; Jaspers A; Baron F; Beguin Y
Am J Hematol; 2021 Oct; 96(10):1275-1286. PubMed ID: 34310730
[TBL] [Abstract][Full Text] [Related]
6. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.
Inomata S; Anan A; Yamauchi E; Yamauchi R; Kunimoto H; Takata K; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Irie M; Shakado S; Sohda T; Sakisaka S
Intern Med; 2019 Oct; 58(20):2915-2922. PubMed ID: 31243222
[TBL] [Abstract][Full Text] [Related]
7. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
Breenfeldt Andersen A; Bonne TC; Bejder J; Jung G; Ganz T; Nemeth E; Olsen NV; Huertas JR; Nordsborg NB
Am J Physiol Regul Integr Comp Physiol; 2021 Aug; 321(2):R152-R161. PubMed ID: 34160288
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion.
Cavallaro F; Duca L; Pisani LF; Rigolini R; Spina L; Tontini GE; Munizio N; Costa E; Cappellini MD; Vecchi M; Pastorelli L
Can J Gastroenterol Hepatol; 2017; 2017():6843976. PubMed ID: 28191453
[No Abstract] [Full Text] [Related]
9. Umbilical Cord Erythroferrone Is Inversely Associated with Hepcidin, but Does Not Capture the Most Variability in Iron Status of Neonates Born to Teens Carrying Singletons and Women Carrying Multiples.
Delaney KM; Guillet R; Pressman EK; Ganz T; Nemeth E; O'Brien KO
J Nutr; 2021 Sep; 151(9):2590-2600. PubMed ID: 34236433
[TBL] [Abstract][Full Text] [Related]
10. Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia.
El-Gamal RAE; Abdel-Messih IY; Habashy DM; Zaiema SEG; Pessar SA
Ann Hematol; 2020 Jan; 99(1):31-39. PubMed ID: 31834456
[TBL] [Abstract][Full Text] [Related]
11. Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?
Bahr TM; Ward DM; Jia X; Ohls RK; German KR; Christensen RD
Blood Cells Mol Dis; 2021 May; 88():102536. PubMed ID: 33450539
[TBL] [Abstract][Full Text] [Related]
12. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents.
Tessitore N; Girelli D; Campostrini N; Bedogna V; Pietro Solero G; Castagna A; Melilli E; Mantovani W; De Matteis G; Olivieri O; Poli A; Lupo A
Nephrol Dial Transplant; 2010 Dec; 25(12):3996-4002. PubMed ID: 20538788
[TBL] [Abstract][Full Text] [Related]
13. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
Zaman BA; Rasool SO; Abdo JM
Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
[TBL] [Abstract][Full Text] [Related]
14. Erythroferrone and hepcidin levels in children with iron deficiency anemia.
Dulkadir R; Turna Saltoğlu G; Güneş A
BMC Pediatr; 2024 Apr; 24(1):240. PubMed ID: 38575873
[TBL] [Abstract][Full Text] [Related]
15. Immunoassay for human serum erythroferrone.
Ganz T; Jung G; Naeim A; Ginzburg Y; Pakbaz Z; Walter PB; Kautz L; Nemeth E
Blood; 2017 Sep; 130(10):1243-1246. PubMed ID: 28739636
[TBL] [Abstract][Full Text] [Related]
16. Functional erythropoietin-hepcidin axis in recombinant human erythropoietin independent haemodialysis patients.
Touzot M; Lefebvre T; Roux A; Maheas C; Ridel C; Puy H; Karim Z
Nephrology (Carlton); 2019 Jul; 24(7):751-757. PubMed ID: 30175513
[TBL] [Abstract][Full Text] [Related]
17. Impact of serum hepcidin and inflammatory markers on resistance to erythropoiesis-stimulating therapy in haemodialysis patients.
El Sewefy DA; Farweez BA; Behairy MA; Yassin NR
Int Urol Nephrol; 2019 Feb; 51(2):325-334. PubMed ID: 30600440
[TBL] [Abstract][Full Text] [Related]
18. Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.
Ciniselli CM; De Bortoli M; Taverna E; Varinelli L; Pizzamiglio S; Veneroni S; Bonini C; Orlandi R; Verderio P; Bongarzone I
Expert Rev Proteomics; 2015; 12(6):695-701. PubMed ID: 26496240
[TBL] [Abstract][Full Text] [Related]
19. Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
Mangaonkar AA; Thawer F; Son J; Ajebo G; Xu H; Barrett NJ; Wells LG; Bowman L; Clair B; Patel N; Bora P; Jung G; Nemeth E; Kutlar A
Br J Haematol; 2020 Jun; 189(6):1204-1209. PubMed ID: 32030737
[TBL] [Abstract][Full Text] [Related]
20. Increased erythroferrone levels in malarial anaemia.
Neyer PJ; Kaboré B; Nakas CT; Diallo S; Tinto H; Post A; van der Ven AJ; Huber AR; Largiadèr CR; Hammerer-Lercher A
Br J Haematol; 2024 May; 204(5):2066-2070. PubMed ID: 38279554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
